Inclusion and Diversity Committee Symposium: Tools to Improve Liver Health Equity

Nov 17 2024
Convention Center: Ballroom 6D
2:00 PM - 3:30 PM
Captured

World Class Speakers

Samuel Sigal, MD, FAASLD
Presenter

Samuel Sigal, MD, FAASLD

NYU Langone Health
Nneka Ufere, MD MSCE
Presenter

Nneka Ufere, MD MSCE

Massachusetts General Hospital
Sharad I Wadhwani, MD, MPH
Presenter

Sharad I Wadhwani, MD, MPH

University of California, San Francisco
David O Garcia, PhD, FACSM
Presenter

David O Garcia, PhD, FACSM

University of Arizona
Amoah Yeboah-Korang, MD
Moderator

Amoah Yeboah-Korang, MD

University of Cincinnati Medical Center
Saikiran M Kilaru, MD
Moderator

Saikiran M Kilaru, MD

New York University

Description

Health disparities in liver disease have long been recognized to affect liver disease morbidity and mortality. There are growing efforts to leverage community-based organizations, electronic medical records (EMRs) and electronic health records (EHRs), social needs screening, and other tools to improve access and outcomes for vulnerable populations. These tools, however, are often developed and implemented in silos around the country. This session provides a platform for sharing strategies, successes, and failures in efforts to improve health disparities in liver disease.

Journey Maps

DEI

Presentations

2:00 PM - 2:18 PM
Nov 17 2024
San Diego, CA

Breaking Down Barriers to Hepatitis B Care: Community- and Faith-Based Collaborations

Samuel Sigal, MD, FAASLD, Presenter
DEI
2:18 PM - 2:36 PM
Nov 17 2024
San Diego, CA

Providing Culturally Competent Palliative Care in Liver Disease

Nneka Ufere, MD MSCE, Presenter
DEI
2:36 PM - 2:54 PM
Nov 17 2024
San Diego, CA

Social Needs Screening to Improve Liver Disease Outcomes

Sharad I Wadhwani, MD, MPH, Presenter
DEI
2:54 PM - 3:12 PM
Nov 17 2024
San Diego, CA

Improving Liver Health Disparities in Native American Populations

David O Garcia, PhD, FACSM, Presenter
DEI

Objectives

  • Describe how big data and machine learning can be leveraged to advance health equity.
  • Review best approaches to maintaining cultural humility and optimal communication around end-of-life discussions among patients with advanced liver disease.
  • Identify key aspects of successful interventions to address disparity in liver disease in various intersectional populations.
  • Summarize key challenges to successful interventions to address disparity in liver disease and approaches to address them.
Chair

Lauren D Nephew, MD, MSCE

Indiana University